Auropharma has been a good performer from the IPO stages. However it entered consolidation stage from 2015-2020. Now the stock is getting ready to move up into new range. Buy for longterm investors.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
